Loading...
One of the most significant advances in HIV clinical medicine during the last year was the introduction of HIV drug-resistance assays. This article summarizes recommendations of an HIV expert panel regarding settings where resistance testing is most likely to improve patient management. Two approaches are used to measure drug susceptibility. Genotypic testing identifies mutational patterns associated with reduced susceptibility. Assays can be performed rapidly, but interpretation can be complex. Phenotypic assays insert a segment of patient virus into a recombinant virus and compare virus production in the presence of drug to that of a laboratory test strain.
The panel recommends resistance testing in 2 clinical settings. In patients with tr…